WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Stock Ownership - Who owns Black Diamond Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Black Diamond Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ali BehbahaniDirector2024-03-153,166$4.54
$14.37kBuy
Wendy L. DixonDirector2024-03-153,253$4.54
$14.77kBuy
Wendy L. DixonDirector2023-12-154,043$2.73
$11.04kBuy
Ali BehbahaniDirector2023-12-154,455$2.73
$12.16kBuy
Growth N. V. Biotech10% Owner2023-10-17400,000$2.34
$934.00kBuy
Mark A. VellecaPRESIDENT CEO2023-09-155,208$3.60
$18.75kBuy
Ali BehbahaniDirector2023-09-153,299$3.60
$11.88kBuy
Wendy L. DixonDirector2023-09-152,986$3.60
$10.75kBuy
Ra Capital Management LPDirector2023-07-05935,850$5.00
$4.68MBuy
Ali BehbahaniDirector2023-07-051,000,000$5.00
$5.00MBuy

1 of 2

BDTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BDTX insiders and whales buy or sell their stock.

BDTX Shareholders

What type of owners hold Black Diamond Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ali Behbahani17.30%8,949,204$44.93MInsider
Bellevue Group Ag16.50%8,535,839$42.85MInstitution
Growth N. V. Biotech16.47%8,517,839$42.76MInsider
Nea Management Company LLC8.60%4,448,757$22.33MInstitution
Versant Venture Capital Vi LP8.37%4,328,883$21.73MInsider
T Rowe Price Investment Management Inc7.59%3,927,879$19.72MInstitution
Ra Capital Management LP6.82%3,525,754$17.70MInstitution
Artal Group Sa3.96%2,046,517$10.27MInstitution
Vanguard Group Inc3.76%1,947,093$9.77MInstitution
Tang Capital Management LLC3.49%1,803,200$9.05MInstitution

1 of 3

BDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BDTX60.10%39.90%Net BuyingNet Buying
VTYX39.06%60.94%Net SellingNet Selling
NKTR64.89%14.15%Net SellingNet Selling
PYXS15.13%36.17%Net Selling
CDXC8.22%91.78%Net Buying
View Top Biotech Stocks

Black Diamond Therapeutics Stock Ownership FAQ

Who owns Black Diamond Therapeutics?

Black Diamond Therapeutics (NASDAQ: BDTX) is owned by 73.68% institutional shareholders, 48.92% Black Diamond Therapeutics insiders, and 0.00% retail investors. Ali Behbahani is the largest individual Black Diamond Therapeutics shareholder, owning 8.95M shares representing 17.30% of the company. Ali Behbahani's Black Diamond Therapeutics shares are currently valued at $44.84M.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.